PTC Therapeutics, Inc.
$59.24
-1.75 (-2.87%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -12.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -19.6%
Own PTCT?
See how PTCT contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.